Pulmonx (LUNG) Earnings Analysis

Pulmonx (LUNG) next reports earnings on 2026-07-29, consensus EPS -0.28 USD. Last quarter (2026-04-29) it beat with EPS -0.33 USD vs -0.33 USD est (0%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -0.93.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LUNG next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate-0.28 USD
Revenue estimate0.02B

LUNG earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-29-0.33 USD-0.33 USD0%Beat
2026-03-04-0.25 USD-0.39 USD+35.9%Beat
2025-11-12-0.34 USD-0.4 USD+15%Beat
2025-04-30-0.36 USD-0.37 USD+2.7%Beat
2025-02-19-0.33 USD-0.45 USD+26.7%Beat
2024-10-30-0.36 USD-0.43 USD+16.3%Beat
2024-07-31-0.39 USD-0.41 USD+4.9%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

LUNG valuation and analyst view

Trailing P/E-0.93
Trailing EPS-1.26998 USD
Price / book1.11
Dividend yield0.00%
Market cap0.05B
Analyst consensusBuy (4 buy / 4 hold / 1 sell)
Avg price target3.25 USD

Related research pages

Frequently asked questions

When is Pulmonx (LUNG)'s next earnings date?

Pulmonx is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -0.28 USD and revenue estimate of 0.02B.

Did LUNG beat earnings last quarter?

In its 2026-04-29 report, LUNG posted EPS of -0.33 USD versus a -0.33 USD estimate — a beat of 0%.

What is LUNG's earnings track record?

Over the last 7 reported quarters with consensus data, LUNG beat estimates 7 times (100%).

What is LUNG's current P/E ratio and EPS?

LUNG trades at a trailing P/E of -0.93 on trailing EPS of -1.2699751864477233 USD.

What do analysts rate LUNG?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 4 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 3.25 USD.